Llwytho...

Understanding how long‐acting β(2)‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an update

In moderate‐to‐severe asthma, adding an inhaled long‐acting β(2)‐adenoceptor agonist (LABA) to an inhaled corticosteroid (ICS) provides better disease control than simply increasing the dose of ICS. Acting on the glucocorticoid receptor (GR, gene NR3C1), ICSs promote anti‐inflammatory/anti‐asthma ge...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Pharmacol
Prif Awduron: Newton, Robert, Giembycz, Mark A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2016
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120156/
https://ncbi.nlm.nih.gov/pubmed/27646470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13628
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!